Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-11-07
DOI
10.3389/fendo.2023.1254398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom
- (2023) Hera Sandhu et al. ADVANCES IN THERAPY
- Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research
- (2023) Yan Xue et al. BMC PUBLIC HEALTH
- Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
- (2023) Marlene Chakhtoura et al. EClinicalMedicine
- Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery
- (2023) Michail Kokkorakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Topiramate (Topamax): Evolving Role in Weight Reduction Management: A Narrative Review
- (2023) Irza Wajid et al. Life-Basel
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
- (2022) Don Husereau et al. VALUE IN HEALTH
- EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model
- (2022) AV Olivieri et al. VALUE IN HEALTH
- Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
- (2021) Young Jin Tak et al. Current Obesity Reports
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Semaglutide for obesity: four STEPs forward, but more to come
- (2021) Donna H Ryan Lancet Diabetes & Endocrinology
- Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis
- (2021) Lin Zhang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Nonsurgical weight loss interventions: A systematic review of systematic reviews and meta‐analyses
- (2021) Laurie K. Twells et al. Obesity Reviews
- Epidemiology and determinants of obesity in China
- (2021) Xiong-Fei Pan et al. Lancet Diabetes & Endocrinology
- European Commission classifies obesity as a chronic disease
- (2021) Talha Burki Lancet Diabetes & Endocrinology
- Clinical management and treatment of obesity in China
- (2021) Qiang Zeng et al. Lancet Diabetes & Endocrinology
- The Most Undertreated Chronic Disease: Addressing Obesity in Primary Care Settings
- (2021) Shanna Tucker et al. Current Obesity Reports
- Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
- (2021) Angeliki M Angelidi et al. ENDOCRINE REVIEWS
- Wegovy (semaglutide): a new weight loss drug for chronic weight management
- (2021) Gurdeep Singh et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
- (2021) Qingyang Shi et al. LANCET
- Anti-obesity drug discovery: advances and challenges
- (2021) Timo D. Müller et al. NATURE REVIEWS DRUG DISCOVERY
- Prevalence of overweight and obesity in China: Results from a cross-sectional study of 441 thousand adults, 2012–2015
- (2020) Linfeng Zhang et al. Obesity Research & Clinical Practice
- Obesity in adults: a clinical practice guideline
- (2020) Sean Wharton et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis
- (2020) Romano Schneider et al. OBESITY SURGERY
- Nearly a decade on — trends, risk factors and policy implications in global obesity
- (2020) Vasanti S. Malik et al. Nature Reviews Endocrinology
- Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
- (2020) Barry M. Popkin et al. Obesity Reviews
- Decomposing adult obesity trends in China (1991–2011)
- (2019) Peng Nie et al. Economics & Human Biology
- Management of overweight and obesity in primary care—A systematic overview of international evidence‐based guidelines
- (2019) Thomas Semlitsch et al. Obesity Reviews
- Prevalence of Obesity and Associated Risk Factors and Cardiometabolic Comorbidities in Rural Northeast China
- (2019) Shiwen Yu et al. Biomed Research International
- Prevalence of overweight and obesity and associated risk factors among adult residents of northwest China: a cross-sectional study
- (2019) Ning Song et al. BMJ Open
- PDB14 COST-EFFECTIVENESS OF CONTRAVE® IN OBESITY MANAGEMENT IN CANADA
- (2019) M. Nuijten et al. VALUE IN HEALTH
- Prevalence and stabilizing trends in overweight and obesity among children and adolescents in China, 2011-2015
- (2018) Jiguo Zhang et al. BMC PUBLIC HEALTH
- Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
- (2018) Alison Avenell et al. HEALTH TECHNOLOGY ASSESSMENT
- Mechanisms, Pathophysiology, and Management of Obesity
- (2017) Steven B. Heymsfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- The lifetime costs of overweight and obesity in childhood and adolescence: a systematic review
- (2017) D. Hamilton et al. Obesity Reviews
- Pathways linking obesity to health-related quality of life
- (2017) Sangshin Park QUALITY OF LIFE RESEARCH
- Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland
- (2017) M Nuijten et al. VALUE IN HEALTH
- Economic Burden of Obesity: A Systematic Literature Review
- (2017) Maximilian Tremmel et al. International Journal of Environmental Research and Public Health
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of obesity
- (2016) George A Bray et al. LANCET
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- European Guidelines for Obesity Management in Adults
- (2015) Volkan Yumuk et al. Obesity Facts
- A systematic review of the cost-effectiveness of non-surgical obesity interventions in men
- (2015) Dwayne Boyers et al. Obesity Research & Clinical Practice
- Modeling the clinical and economic implications of obesity using microsimulation
- (2015) W. Su et al. JOURNAL OF MEDICAL ECONOMICS
- What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.
- (2014) R Ara et al. HEALTH TECHNOLOGY ASSESSMENT
- Reducing the global prevalence of overweight and obesity
- (2014) Klim McPherson LANCET
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Meta- and cost-effectiveness analysis of commercial weight loss strategies
- (2014) Eric A. Finkelstein et al. Obesity
- Cost-Effectiveness Analysis of Qsymia for Weight Loss
- (2014) Eric A. Finkelstein et al. PHARMACOECONOMICS
- The disproportionate economic burden associated with severe and complicated obesity: a systematic review
- (2013) E. Grieve et al. Obesity Reviews
- Global obesity: trends, risk factors and policy implications
- (2012) Vasanti S. Malik et al. Nature Reviews Endocrinology
- Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
- (2012) Andrew H. Briggs et al. VALUE IN HEALTH
- Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
- (2012) David M. Eddy et al. VALUE IN HEALTH
- Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
- (2011) J. Lennert Veerman et al. PLoS One
- Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review
- (2008) M Neovius et al. INTERNATIONAL JOURNAL OF OBESITY
- Cost-Effectiveness of a Low-Calorie Diet and Orlistat for Obese Persons: Modeling Long-Term Health Gains through Prevention of Obesity-Related Chronic Diseases
- (2008) Pieter H.M. van Baal et al. VALUE IN HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search